Temat: Basal cell carcinoma - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Skin of sailor: cutis rhomboidalis nuchae, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Case report
Autorzy:: Abdulaziz, Ahmad
Brzeziński, Piotr
Chiriac, Anca
Powiązania:: https://bibliotekanauki.pl/articles/1065852.pdf
Data publikacji:: 2014
Wydawca:: Medical Education
Tematy:: actinic keratosis
basal cell carcinoma
sailor
squamous cell carcinoma
ultraviolet
Opis:: Chronic exposure to environmental ultraviolet radiation (UVR) plays a key role both in photocarcinogenesis and induction of accelerated skin ageing. Sailors commonly experience a significant number of cutaneous problems, related to the exposure to environmental factors due to their working conditions. Among these factors, sun exposure is able to determine both acute and chronic skin damage, mostly linked to the effects of the ultraviolet (UV) radiation on epidermal and dermal structures. We report a case of sailor with cutis rhomboidalis nuchae, solar elastosis, actinic keratosis (AK), numerous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) of the head and trunk.
Źródło:: OncoReview; 2014, 4, 1; A37-41
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Skocz do pozycji: 2.

Tytuł:: Treatment of multiple superficial basal cell carcinomas with topical imiquimod
Autorzy:: Brzeziński, Piotr
Chiriac, Anca
Powiązania:: https://bibliotekanauki.pl/articles/1065071.pdf
Data publikacji:: 2015
Wydawca:: Medical Education
Tematy:: basal cell carcinoma (BCC)
cryotherapy
imiquimod 5% cream
Opis:: Basal cell carcinoma is the most common malignancy of man. The use of the topical imiquimod 5% cream offers a noninvasive, nonsurgical, and an effective option for the treatment of primary types superficial basal cell carcinoma (sBCC). We present a case series of patients who used imiquimod 5% cream with good therapeutic effect. The medication had a good tolerability profile and there were no ocular adverse events. Imiquimod 5% cream could be considered the first choice treatment for BCCs in older patients who are poor candidates to surgery.
Źródło:: OncoReview; 2015, 5, 1; A42-A45
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Informacja